Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Viamet and Novartis partner for metalloenzyme inhibitors

Feb. 23, 2010

Ceragenix and BexPharm enter into agreement for EpiCeram

Feb. 23, 2010

Chugai licenses Roche's Hedgehog pathway inhibitor RG-3616 in Japan

Feb. 19, 2010

Thallion and LFB sign agreement to develop STEC infection therapy

Feb. 19, 2010

SurModics to terminate license agreement with Ambrilia Biopharma

Feb. 19, 2010

Paladin amends R&D agreement with Isotechnika for diagnostic products

Feb. 19, 2010

TD2 and Rondaxe sign alliance to help emerging companies develop cancer therapeutics

Feb. 18, 2010

MorphoSys and Galapagos add another antibody target to alliance in bone and joint diseases

Feb. 18, 2010

Lung Rx and ImmuneWorks sign development agreement for IW-001 in IPF and PGD

Feb. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...